Supplemental Methods

Protein Purification and Fluorescent Labelling of C99, Cav3, PMP22, and ctxB
To facilitate fluorescent labeling of these proteins, cysteine residues were introduced into the C99 and Cav3 genes. C99 studies were carried out using a single-cysteine variant (F675C) of human C99. Cav3 studies were also carried out using a single-cysteine variant (V25C) of human Cav3, which was produced in the background of an otherwise cysteine-free construct described previously (1). PMP22 studies were carried out using the wild-type form of human PMP22, which contains four native cysteines. Mutant constructs were produced using Quickchange Mutagenesis. Alexafluor 488-labeled ctxB was purchased from Invitrogen (San Diego, CA).
C99 was expressed and purified as described previously (2) , except the protein was exchanged into SDS micelles on column and eluted in 20 mM Tris (pH 7.8) containing 200 mM NaCl, 250 mM imidazole, and 0.2 % SDS (w/v). The pH was then lowered to 6.5 with HCl prior to a 10-fold concentration of the sample using an Amicon 10 KDa MWCO centrifugational concentrator (Millipore, Billerica, MA). To reduce disulfide bonds, a 100 mM TCEP (pH 6.5) stock solution was then added to a final concentration of 5 mM prior to tumbling the sample overnight at room temperature. Cav3 was expressed and purified as described previously (1), except the protein was exchanged into SDS on column and eluted in 250 mM imidazole (pH 6.5) containing 2 mM TCEP and 0.2% SDS (w/v). Wild-type PMP22 was expressed and purified as described previously (3) . Protein stocks were flash-frozen and in liquid nitrogen and stored at -30° C until use.
To fluorescently label the proteins, concentrated protein stock solutions were diluted into 40 mM HEPES (pH 7.5) containing 150 mM NaCl and 5% (w/v) SDS to a final protein concentration of 10 µM. 10 mM stock solutions of either Alexa Fluor 488 C5 maleimide, Alexa Fluor 633 C5 maleimide, or Bodipy-FL maleimide (Life Technologies, Grand Island, NY) in DMSO were then diluted 100-fold into the solutions to initiate labeling. Labeling reactions were then covered in argon gas, sealed, and tumbled in the dark at room temperature overnight. SDS was used as a solubilizing detergent for labeling in order to prevent aggregation and to ensure the proteins remained monomeric throughout the course of the reaction. To remove unreacted fluorophore, the samples were then passed through two consecutive 5 mL 7 KDa MWCO Zeba desalting columns (Life Technologies, Grand Island, NY), which were pre-equilibrated with 40 mM HEPES (pH 7.5) containing 150 mM NaCl and 5% (w/v) SDS according to the manufacturer's instructions.
Reconstitution into Proteoliposomes
Stock solutions of the lipids 1-palmitoyl-2-oleoyl-sn-glycero Residual solvent was then removed by freeze-drying the samples for at least 3 hours. The lipid mixture was then solubilized in mixed micelles by adding 40 mM HEPES (pH 7.5) containing 150 mM NaCl, 3.4% (w/v) SDS, and the fluorescently-labeled target protein to the tube and mixing by vortex for 2 minutes under argon gas. The final concentration of lipids and protein were 1.2 mM and 3 µM, respectively (400:1 molar lipid: protein). Mixed micelles were then equilibrated by tumbling the samples in the dark for at least 1 hour at room temperature.
Rapid removal of solubilizing detergents was previously found to increase the homogeneity of the resulting proteoliposomes (4). To produce homogenous unilamellar proteoliposomes, SDS was rapidly and selectively precipitated using a modified version of a previously reported reconstitution protocol (5). SDS was precipitated by adding the appropriate volume of 4M KCl to achieve a 1:1 molar ratio of K + to dodecyl sulfate. The samples were then mixed by vortex for 10 seconds and centrifuged for 15 minutes at 14,000 rpm to pellet the precipitated detergent. The supernatant was then transferred to 12-14 KDa MWCO dialysis tubing (Spectrum Labs, Rancho Dominguez, CA) and dialyzed in the dark against 4 L of 10 mM HEPES (pH 7.5) in order to remove residual detergent and salt. Dialysis was allowed to proceed for up to two days with regular changes of the bath until no detergent could be detected in the dialysis bath. Proteoliposomes were either stored under argon at 4° C in the dark for short term use or flash-frozen for long term storage.
GUV formation and Confocal Fluorescence Microscopy
GUV's were formed from proteoliposomes using a protocol based on that of Girard et al. (6) Briefly, an array of 2 µL drops of the proteoliposome solutions were deposited on the surface of indium tin oxide-coated glass slides and dried under controlled humidity in a desiccator containing a saturated sodium chloride solution for one hour in the dark. A chamber was then formed around the semi-dry proteoliposome films using a rubber O-ring with a thin coating of silicon grease (Corning, Corning, NY). The chamber was then filled with 100 mM sucrose prior to sealing the chamber by applying a second indium tin oxide-coated slide to the top of the Oring. The slides were then clipped together and connected to electrodes in a manner to allow passage of current through the chamber. A wave generator was then used to pass a sinusoidal current through the chamber with a frequency of 10 Hz at 1 V. Electroswelling of GUVs was allowed to proceed for at least 2 hours in the dark at 50° C. The sucrose solution containing
GUVs was then added dropwise to a glass test tube containing 3 mL of 100 mM glucose that was pre-warmed to 50° C prior to incubation at room temperature for at least 20 minutes in the dark. were counted in the analysis.
